Atlas Trials

Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)

Clinical trial NCT03411941 · COMPLETED

Trial details

NCT number
NCT03411941
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Macular Degeneration
Start date
2018-02-28
Primary completion
2019-03-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.